Clinical Trial Update: Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating radiotherapy with nimotuzumab or cisplatin in nasopharyngeal carcinoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING